Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02763267 · ClinicalTrials.gov registry record
Study of Pregnancy Regulation of Insulin and Glucose
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 234
- Enrollment target
NCT02763267: Completed study, sponsored by Massachusetts General Hospital.
NCT02763267 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 234 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02763267 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
It is unknown whether beta cell dysfunction and insulin resistance in Gestational Diabetes Mellitus (GDM) is representative of a chronic maternal defect, unmasked by pregnancy, or whether it is the result of an imbalance of a placental hormones. Undiscovered placental factors which vary between pregnancies likely contribute to the pathogenesis of GDM. To elucidate the pathophysiology underlying GDM, the investigators will attempt to discover these factors and characterize pregnancy-associated changes in insulin secretion and sensitivity in women with and without GDM.
Interventions
- OTHER Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2016-02 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02763267
The ClinicalTrials.gov registry entry for NCT02763267 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT02763267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02763267 about?
NCT02763267 is a clinical study titled "Study of Pregnancy Regulation of Insulin and Glucose". It is unknown whether beta cell dysfunction and insulin resistance in Gestational Diabetes Mellitus (GDM) is representative of a chronic maternal defect, unmasked by pregnancy, or whether it is the result of an imbalance of a placental hormones. Undiscovered placental factors which vary between preg...
What is the current status of trial NCT02763267?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2016-02. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02763267?
The interventions under investigation include: Oral glucose tolerance test (OTHER).
Who is sponsoring clinical trial NCT02763267?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.